{"transactions":[{"id":1646072,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-14T02:46:14.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":4376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":4376,"derivative":{"exercise_price":194.87,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":4376},"source":{"system":"sec-edgar","filing":"0001104659-24-022573","document":"tm245999-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924022573/tm245999-6_4seq1.xml","form_type":"4"}},{"id":1646071,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-14T02:46:14.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":2694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"Plan\") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023."}],"balance_after":3027,"source":{"system":"sec-edgar","filing":"0001104659-24-022573","document":"tm245999-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924022573/tm245999-6_4seq1.xml","form_type":"4"}},{"id":2003458,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-21T23:54:58.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option has vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":10300,"derivative":{"exercise_price":194.82,"expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001104659-23-023901","document":"tm237460-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923023901/tm237460-1_4seq1.xml","form_type":"4"}},{"id":2003457,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-21T23:54:58.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":7000,"price":275,"value":1925000.0,"ownership":{"direct":true},"balance_after":243,"source":{"system":"sec-edgar","filing":"0001104659-23-023901","document":"tm237460-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923023901/tm237460-1_4seq1.xml","form_type":"4"}},{"id":2003456,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-21T23:54:58.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":7000,"price":194.82,"value":1363740.0,"ownership":{"direct":true},"balance_after":7243,"source":{"system":"sec-edgar","filing":"0001104659-23-023901","document":"tm237460-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923023901/tm237460-1_4seq1.xml","form_type":"4"}},{"id":2016332,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-15T01:00:19.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":5450,"derivative":{"exercise_price":263.16,"expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0001104659-23-022085","document":"tm236006-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923022085/tm236006-9_4seq1.xml","form_type":"4"}},{"id":2016331,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-15T01:00:19.000Z","date":"2022-11-18","kind":"gift","acquired":false,"shares":167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects (a) (i) 167 shares acquired under the Inspire Medical Systems, Inc. (the \"Company\") 2018 Employee Stock Purchase Plan (the \"ESPP\") on December 31, 2020, (ii) 81 shares acquired under the ESPP on June 30, 2021, (iii) 51 shares acquired under the ESPP on December 31, 2021, (iv) 80 shares acquired under the ESPP on June 30, 2022 and (v) 31 shares acquired under the ESPP on December 31, 2022, minus (b) the 167 shares gifted on November 18, 2022."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001104659-23-022085","document":"tm236006-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923022085/tm236006-9_4seq1.xml","form_type":"4"}},{"id":2394480,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-15T21:31:12.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":5924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":5924,"derivative":{"exercise_price":227.53,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":5924},"source":{"system":"sec-edgar","filing":"0001104659-22-023821","document":"tm226817-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465922023821/tm226817-2_4seq1.xml","form_type":"4"}},{"id":2942567,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-16T22:56:52.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":17300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":17300,"derivative":{"exercise_price":194.82,"expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":17300},"source":{"system":"sec-edgar","filing":"0001104659-20-136414","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465920136414/a4.xml","form_type":"4"}},{"id":3095209,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-07-01T20:17:06.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of June 30, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates."}],"balance_after":40000,"derivative":{"exercise_price":87.02,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-079720","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465920079720/a4.xml","form_type":"4"}},{"id":4497311,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":2736,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2736},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497310,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":34376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":61.62,"exercise_date":"2016-12-17","expiration_date":"2023-12-07","underlying":"Common Stock","underlying_shares":34376},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497309,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":938,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497308,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":12740,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":12740},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497307,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":502,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":502},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497306,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":8799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":8799},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497305,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":11264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":11264},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497304,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4497303,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-01-06T13:14:52.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":3113,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories (\"Abbott\"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the \"Merger Agreement\"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the \"Merger Consideration\"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000590","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000590/edgar.xml","form_type":"4"}},{"id":4516364,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2736,"derivative":{"exercise_date":"2016-12-17","underlying":"Common Stock","underlying_shares":3648},"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516363,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock units","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":938,"derivative":{"exercise_date":"2015-12-17","underlying":"Common Stock","underlying_shares":1407},"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516362,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":502,"derivative":{"exercise_date":"2014-12-17","underlying":"Common Stock","underlying_shares":1004},"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516361,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":0,"derivative":{"exercise_date":"2013-12-17","underlying":"Common Stock","underlying_shares":704},"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516360,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":307,"price":79.2,"value":24314.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"912 shares of restricted stock vested on December 17, 2016. 307 shares were used to pay taxes and 605 shares were released."}],"balance_after":3113,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516359,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":3420,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516358,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":158,"price":79.2,"value":12513.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"469 shares of restricted stock vested on December 17, 2016. 158 shares were used to pay taxes and 311 shares were released."}],"balance_after":2508,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516357,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2666,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516356,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":169,"price":79.2,"value":13384.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"502 shares of restricted stock vested on December 17, 2016. 169 shares were used to pay taxes and 333 shares were released."}],"balance_after":2197,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516355,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2366,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516354,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":237,"price":79.2,"value":18770.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"704 shares of restricted stock vested on December 17, 2016. 237 shares were used to pay taxes and 467 shares were released."}],"balance_after":1864,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}},{"id":4516353,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":94367,"kind":"person","name":"Ebeling Philip","position":1,"cik":"0001662781","reported_name":"Ebeling Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:56:50.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2101,"source":{"system":"sec-edgar","filing":"0001179110-16-033306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033306/edgar.xml","form_type":"4"}}]}